Updating pregnancy diabetes guidelines: is (y)our laboratory ready?

Sjoerd A A van den Berg; Sjoerd W van Thiel; Marc H M Thelen

doi:10.1515/cclm-2015-1111

Updating pregnancy diabetes guidelines: is (y)our laboratory ready?

Sjoerd A A van den Berg^*, Sjoerd W van Thiel, Marc H M Thelen

^*Corresponding author for this work

Amphia Hospital

Research output: Contribution to journal › Article › Academic › peer-review

8 Citations (Scopus)

Abstract

To the Editor,
Recently, there has been a global trend towards update of clinical guidelines concerning pregnancy diabetes. More specifically, guidelines are updated to decision limits proposed by the International Association of the Diabetes and Pregnancy Study Groups (IADPSG) during the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study [1]. In the HAPO study, cut-off values for the 75 g oral
glucose tolerance test were set based on clinical outcome of more than 25,000 pregnancies. In this time and era, it is common for medical professionals to adopt evidence based protocols. Unfortunately, verification whether local protocols for analysis and pre-analysis are functionally equivalent to those in the guidelines in order to make the decision limits valid for local
measurements is often overlooked. [...]

Original language	English
Pages (from-to)	e225-7
Journal	Clinical Chemistry and Laboratory Medicine
Volume	54
Issue number	8
DOIs	https://doi.org/10.1515/cclm-2015-1111
Publication status	Published - 1 Aug 2016
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1515/cclm-2015-1111

Cite this

@article{3d9d286207f540bcbcb12b248883b5e3,

title = "Updating pregnancy diabetes guidelines: is (y)our laboratory ready?",

abstract = "To the Editor, Recently, there has been a global trend towards update of clinical guidelines concerning pregnancy diabetes. More specifically, guidelines are updated to decision limits proposed by the International Association of the Diabetes and Pregnancy Study Groups (IADPSG) during the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study [1]. In the HAPO study, cut-off values for the 75 g oral glucose tolerance test were set based on clinical outcome of more than 25,000 pregnancies. In this time and era, it is common for medical professionals to adopt evidence based protocols. Unfortunately, verification whether local protocols for analysis and pre-analysis are functionally equivalent to those in the guidelines in order to make the decision limits valid for local measurements is often overlooked. [...]",

author = "\{van den Berg\}, \{Sjoerd A A\} and \{van Thiel\}, \{Sjoerd W\} and Thelen, \{Marc H M\}",

year = "2016",

month = aug,

day = "1",

doi = "10.1515/cclm-2015-1111",

language = "English",

volume = "54",

pages = "e225--7",

journal = "Clinical Chemistry and Laboratory Medicine",

issn = "1434-6621",

publisher = "De Gruyter",

number = "8",

}

TY - JOUR

T1 - Updating pregnancy diabetes guidelines

T2 - is (y)our laboratory ready?

AU - van den Berg, Sjoerd A A

AU - van Thiel, Sjoerd W

AU - Thelen, Marc H M

PY - 2016/8/1

Y1 - 2016/8/1

N2 - To the Editor, Recently, there has been a global trend towards update of clinical guidelines concerning pregnancy diabetes. More specifically, guidelines are updated to decision limits proposed by the International Association of the Diabetes and Pregnancy Study Groups (IADPSG) during the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study [1]. In the HAPO study, cut-off values for the 75 g oral glucose tolerance test were set based on clinical outcome of more than 25,000 pregnancies. In this time and era, it is common for medical professionals to adopt evidence based protocols. Unfortunately, verification whether local protocols for analysis and pre-analysis are functionally equivalent to those in the guidelines in order to make the decision limits valid for local measurements is often overlooked. [...]

AB - To the Editor, Recently, there has been a global trend towards update of clinical guidelines concerning pregnancy diabetes. More specifically, guidelines are updated to decision limits proposed by the International Association of the Diabetes and Pregnancy Study Groups (IADPSG) during the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study [1]. In the HAPO study, cut-off values for the 75 g oral glucose tolerance test were set based on clinical outcome of more than 25,000 pregnancies. In this time and era, it is common for medical professionals to adopt evidence based protocols. Unfortunately, verification whether local protocols for analysis and pre-analysis are functionally equivalent to those in the guidelines in order to make the decision limits valid for local measurements is often overlooked. [...]

U2 - 10.1515/cclm-2015-1111

DO - 10.1515/cclm-2015-1111

M3 - Article

C2 - 26812793

SN - 1434-6621

VL - 54

SP - e225-7

JO - Clinical Chemistry and Laboratory Medicine

JF - Clinical Chemistry and Laboratory Medicine

IS - 8

ER -

Updating pregnancy diabetes guidelines: is (y)our laboratory ready?

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this